• en
  • it
  • de
  • Direzione

    Dr. Oliver Bolzern, PhD
    Chief Executive Officer (CEO)

    Oliver Bolzern studied Chemical Engineering at ETH Zurich, where he also earned his PhD. He has broad international experience, particularly in the fields of operations and development in the pharmaceutical industry. He has been the CEO of the Pharmazell Group since 2006.

    Torsten Byl
    Chief Finance Officer (CFO)

    Torsten Byl studied Industrial Engineering in Wilhelmshaven. He started his professional career as a controller and financial analyst in the consumer goods industry. He moved into the food industry, becoming managing director for controlling, finance, production, quality and purchasing. His last appointment was to the Board of Directors of Klemme AG, a company of the ARYZTA Group.

    Michel Blanc
    Chief Business Development Officer (CBDO)

    Michel Blanc studied Chemical Engineering and Organic Chemistry in Marseille (France). He started his professional career at ICI and Zeneca, acquiring many years of international experience in different industries. He has more than 15 years of experience in the pharmaceutical industry, working in key decision-making roles in business development for both API and FDF.

    Stephan Bregy
    Chief Sales & Marketing Officer (EVP)

    Stephan Bregy has more than 20 years of experience in the Life Sciences Industry. He has worked in various managerial positions with international responsibilities, at Lonza, DePuy Synthes and Siegfried. Mr. Bregy studied chemistry at the Federal Institute of Technology, Zürich and completed a business degree from the University of Lausanne, Switzerland. He joined PharmaZell as Head of Global Sales and Marketing in March 2017.

    Marcus Dohmann
    Chief Supply Chain Officer (CSCO)

    Marcus Dohmann studied Business Economics at the VWA Cologne. He has many years of international experience in Supply Chain, Operations and Purchasing Management. He has more than 15 years of experience in the pharmaceutical and chemical industry in several leadership positions, both nationally and internationally. He has worked for Schwarz Pharma, Ebewe, Sandoz and Lohmann.

    Dr. Kai Donsbach, PhD
    Chief Technology Officer (CTO)

    Dr. Kai Donsbach studied Chemistry at the universities of Mainz and Irvine, California and obtained his PhD in Chemistry from Mainz. He has more than 15 years of international experience in R&D production and project management, working with Boehringer Ingelheim and DSM.

    Dr. Kurt Mayrhofer, PhD
    Chief Compliance Officer (CCO)

    Dr. Kurt Mayrhofer studied food chemistry at LMU Munich, where he also obtained his PhD in Pharmaceutical Chemistry. He is responsible for Global Quality Operations and Regulatory Compliance and is Qualified Person. He has more than 25 years of experience in the pharmaceutical industry and is responsible for the PharmaZell Group compliance program.

    Mario Di Giacomo
    Chief Operating Officer (COO) Europe

    Mario Di Giacomo studied chemical engineering at Bologna University (Italy). He has more than 15 years of experience in project execution, production, technology and management in various fields of the chemical and pharmaceutical industry.

    Anant Barbadikar
    Chief Operating Officer (COO) India

    Anant Barbadikar is a chemical engineering graduate. He has more than twenty years of experience in project execution and manufacturing in various pharmaceutical and chemical industries.